Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2026 Filed Jan 5, 2026 21:10 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 5,958 | $1.93 | $11,498.94 |
DisclosureSEC source: 0001470831-26-000009 · wk-form4_1767647442.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,532 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:10 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 7,513 | $1.93 | $14,500.09 |
DisclosureSEC source: 0001470831-26-000008 · wk-form4_1767647408.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,142 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 16:30 UTC |
Mahaney PaigeChief Scientific Officer
|
Tax withholdingCommon Stock | 5,644 | $2.58 | $14,561.52 |
DisclosureSEC source: 0001193125-25-258664 · ownership.xml · nonDerivative · entry 2 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,356 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 16:30 UTC |
Mahaney PaigeChief Scientific Officer
|
Exercise / conversionCommon Stock | 19,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-258664 · ownership.xml · nonDerivative · entry 1 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:14 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 5,349 | $2.15 | $11,500.35 |
DisclosureSEC source: 0001470831-25-000250 · wk-form4_1759522454.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,574 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:13 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 6,740 | $2.15 | $14,491.00 |
DisclosureSEC source: 0001470831-25-000249 · wk-form4_1759522434.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,629 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2025. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 16:13 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 2,775 | $3.32 | $9,213.00 |
DisclosureSEC source: 0001470831-25-000223 · wk-form4_1758312827.xml · nonDerivative · entry 2 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,342 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| September 18, 2025 Filed Sep 19, 2025 16:13 UTC |
Adams KendraChief Financial Officer
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-25-000223 · wk-form4_1758312827.xml · nonDerivative · entry 1 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023. Read SEC document |
| July 10, 2025 Filed Jul 14, 2025 20:19 UTC |
REYNO LEONARDChief Medical Officer
|
Tax withholdingCommon Stock | 7,382 | $1.99 | $14,690.18 |
DisclosureSEC source: 0001662579-25-000055 · wk-form4_1752524362.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,382 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| July 10, 2025 Filed Jul 15, 2025 13:00 UTC Amendment |
REYNO LEONARDChief Medical Officer
|
Tax withholdingCommon Stock | 7,382 | $1.99 | $14,690.18 |
DisclosureSEC source: 0001662579-25-000057 · wk-form4a_1752584408.xml · nonDerivative · entry 2 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,382 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| July 10, 2025 Filed Jul 15, 2025 13:00 UTC Amendment |
REYNO LEONARDChief Medical Officer
|
Exercise / conversionCommon Stock | 15,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000057 · wk-form4a_1752584408.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This amendment to the Form 4 originally filed on July 14, 2025 is being filed voluntarily to report the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:17 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 7,616 | $1.51 | $11,500.16 |
DisclosureSEC source: 0001662579-25-000053 · wk-form4_1751487429.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,225 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025. Read SEC document |
| July 01, 2025 Filed Jul 2, 2025 20:17 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 9,609 | $1.51 | $14,509.59 |
DisclosureSEC source: 0001662579-25-000052 · wk-form4_1751487418.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,889 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2025. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:11 UTC |
Fawell StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000047 · wk-form4_1750450293.xml · derivative · entry 1 Fawell Stephen · CIK 0002033387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:11 UTC |
Hughes OwenDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000048 · wk-form4_1750450303.xml · derivative · entry 1 Hughes Owen · CIK 0001575933 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:10 UTC |
Hoerter Steven L.Director
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000042 · wk-form4_1750450241.xml · derivative · entry 1 Hoerter Steven L. · CIK 0001533451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:12 UTC |
Koppikar UtpalDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000049 · wk-form4_1750450313.xml · derivative · entry 1 Koppikar Utpal · CIK 0001742696 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:11 UTC |
Anderson Kenneth CarlDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000046 · wk-form4_1750450283.xml · derivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:11 UTC |
Bessen LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000045 · wk-form4_1750450270.xml · derivative · entry 1 Bessen Laura · CIK 0001926815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:11 UTC |
GROGAN DONNA ROYDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000044 · wk-form4_1750450260.xml · derivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 20:10 UTC |
Cooper Ronald Harold WilfredDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,500 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001662579-25-000043 · wk-form4_1750450250.xml · derivative · entry 1 Cooper Ronald Harold Wilfred · CIK 0001676880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,500 Underlying: Common Stock · 35,500 shares Expires 2035-06-17 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2026 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:11 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 9,581 | $1.44 | $13,748.74 |
DisclosureSEC source: 0001662579-25-000025 · wk-form4_1743711105.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,280 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:11 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 7,841 | $1.44 | $11,251.84 |
DisclosureSEC source: 0001662579-25-000024 · wk-form4_1743711094.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,609 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2025. Read SEC document |
| February 18, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
SaleCommon Stock | 669 | $3.15 | $2,107.35 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 5 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,805 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024. Read SEC document |
| February 15, 2025 Filed Feb 18, 2025 21:55 UTC |
Hirsch AndrewDirector · President & CEO
|
Tax withholdingCommon Stock | 9,370 | $3.18 | $29,796.60 |
DisclosureSEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 3 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,145 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,700 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · derivative · entry 6 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,700 Underlying: Common Stock · 84,700 shares Expires 2035-02-13 F4 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
Tax withholdingCommon Stock | 2,368 | $3.18 | $7,530.24 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 4 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,474 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
SaleCommon Stock | 490 | $3.15 | $1,543.50 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 3 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,842 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2024. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
GrantCommon Stock | 56,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 2 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,332 F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:54 UTC |
Mahaney PaigeChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,400 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000015 · wk-form4_1739915672.xml · derivative · entry 2 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,400 Underlying: Common Stock · 42,400 shares Expires 2035-02-13 F2 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:54 UTC |
Mahaney PaigeChief Scientific Officer
|
GrantCommon Stock | 28,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000015 · wk-form4_1739915672.xml · nonDerivative · entry 1 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Mossler MarkChief Accounting Officer
|
Tax withholdingCommon Stock | 1,586 | $3.18 | $5,043.48 |
DisclosureSEC source: 0001662579-25-000018 · wk-form4_1739915700.xml · nonDerivative · entry 1 Mossler Mark · CIK 0001992219 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,204 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:54 UTC |
Adams KendraChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,600 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · derivative · entry 4 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,600 Underlying: Common Stock · 130,600 shares Expires 2035-02-13 F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:54 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 4,559 | $3.18 | $14,497.62 |
DisclosureSEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 3 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,117 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:54 UTC |
Adams KendraChief Financial Officer
|
GrantCommon Stock | 87,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 2 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,676 F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
REYNO LEONARDChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 130,600 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · derivative · entry 3 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,600 Underlying: Common Stock · 130,600 shares Expires 2035-02-13 F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
REYNO LEONARDChief Medical Officer
|
Tax withholdingCommon Stock | 5,145 | $3.18 | $16,361.10 |
DisclosureSEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · nonDerivative · entry 2 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,764 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
REYNO LEONARDChief Medical Officer
|
GrantCommon Stock | 87,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000014 · wk-form4_1739915661.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,909 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Hirsch AndrewDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 335,300 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · derivative · entry 4 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,300 Underlying: Common Stock · 335,300 shares Expires 2035-02-13 F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Hirsch AndrewDirector · President & CEO
|
Tax withholdingCommon Stock | 12,847 | $3.18 | $40,853.46 |
DisclosureSEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432,515 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Hirsch AndrewDirector · President & CEO
|
GrantCommon Stock | 223,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000021 · wk-form4_1739915729.xml · nonDerivative · entry 1 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,362 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Siegel JolieChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,700 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · derivative · entry 4 Siegel Jolie · CIK 0001768223 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,700 Underlying: Common Stock · 84,700 shares Expires 2035-02-13 F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Siegel JolieChief Legal Officer
|
Tax withholdingCommon Stock | 2,914 | $3.18 | $9,266.52 |
DisclosureSEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 3 Siegel Jolie · CIK 0001768223 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,939 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:55 UTC |
Siegel JolieChief Legal Officer
|
GrantCommon Stock | 56,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 2 Siegel Jolie · CIK 0001768223 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,853 F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
Schick KellyChief People Officer
|
GrantStock Option (Right to Buy) · Derivative | 84,700 | $0.00 Strike: $3.18 | $0.00 |
DisclosureSEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · derivative · entry 4 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,700 Underlying: Common Stock · 84,700 shares Expires 2035-02-13 F3 · derivative.exercise_date: The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
Schick KellyChief People Officer
|
Tax withholdingCommon Stock | 2,368 | $3.18 | $7,530.24 |
DisclosureSEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · nonDerivative · entry 3 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,885 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 21:54 UTC |
Schick KellyChief People Officer
|
GrantCommon Stock | 56,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001662579-25-000017 · wk-form4_1739915691.xml · nonDerivative · entry 2 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,253 F2 · shares: Represents RSUs. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 16:55 UTC |
Boyle Scott NChief Business Officer
|
Tax withholdingCommon Stock | 1,735 | $3.20 | $5,552.00 |
DisclosureSEC source: 0001662579-25-000019 · wk-form4_1739915710.xml · nonDerivative · entry 1 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,832 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 16:54 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 1,863 | $3.20 | $5,961.60 |
DisclosureSEC source: 0001662579-25-000016 · wk-form4_1739915682.xml · nonDerivative · entry 1 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,576 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:55 UTC |
Siegel JolieChief Legal Officer
|
Tax withholdingCommon Stock | 2,135 | $3.20 | $6,832.00 |
DisclosureSEC source: 0001662579-25-000020 · wk-form4_1739915720.xml · nonDerivative · entry 1 Siegel Jolie · CIK 0001768223 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,353 F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs") and does not represent a sale by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.